Checkpoint inhibition for advanced mucosal melanoma

Julia Thierauf,Johannes A. Veit,Jochen Hess,Nicolai Treiber,Catharina Lisson,Stephanie E Weissinger,Martin Bommer,Thomas K. Hoffmann

Checkpoint inhibition for advanced mucosal melanoma

2017

Julia Thierauf
Johannes A. Veit
Jochen Hess
Nicolai Treiber
Catharina Lisson
Stephanie E Weissinger
Martin Bommer
Thomas K. Hoffmann

Background Whereas anti-PD-1 therapy has demonstrated a significant and durable response against advanced cutaneous melanoma, conventional chemotherapies have shown only minor benefit against advanced mucosal melanoma.

Keywords:

Dermatology
Medicine
Ipilimumab
Nivolumab
Melanoma
Mucosal melanoma
Oncology
Pembrolizumab
Internal medicine
head and neck
cutaneous melanoma
immune checkpoint inhibitors
anti pd 1

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations